Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Other Accumulated Expenses (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Other Accumulated Expenses for 8 consecutive years, with $274.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Accumulated Expenses fell 5.06% to $274.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $274.1 million, a 5.06% decrease, with the full-year FY2025 number at $274.1 million, down 5.06% from a year prior.
  • Other Accumulated Expenses was $274.1 million for Q4 2025 at Select Medical Holdings, up from $247.6 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $355.2 million in Q3 2024 to a low of $226.3 million in Q4 2023.
  • A 5-year average of $272.5 million and a median of $266.9 million in 2022 define the central range for Other Accumulated Expenses.
  • Peak YoY movement for Other Accumulated Expenses: surged 30.37% in 2021, then plummeted 30.3% in 2025.
  • Select Medical Holdings' Other Accumulated Expenses stood at $244.4 million in 2021, then grew by 8.23% to $264.5 million in 2022, then decreased by 14.44% to $226.3 million in 2023, then increased by 27.55% to $288.7 million in 2024, then dropped by 5.06% to $274.1 million in 2025.
  • Per Business Quant, the three most recent readings for SEM's Other Accumulated Expenses are $274.1 million (Q4 2025), $247.6 million (Q3 2025), and $286.4 million (Q2 2025).